Bailin Jiang

Dr. Bailin Jiang


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2025 in BMC Medicine
Verified
Journal Article
Open access
PDF file
ANAyixia Nawan
Ayixia Nawan
ZWZilong Wu
Zilong Wu
BJBailin Jiang
Bailin Jiang
GWGeng Wang
Geng Wang
WZWenchao Zhang
Wenchao Zhang
YFYi Feng
Yi Feng
Background: Postoperative delirium is the most common complication in older patients and is associated with surgery-induced inflammation. Although inflammation plays a key role in delirium, the potential benefits of a comprehensive anti-inflammatory approach to managing perioperative systemic inflammation remain underexplored. This study evaluated whether a perioperative anti-inflammatory bundle strategy, combining dexmedetomidine, glucocorticoids, ulinastatin, and nonsteroidal anti-inflammatory drugs, reduces the risk of postoperative delirium in older patients undergoing hip fracture surgery. Methods: This dual-center, double-blind, placebo-controlled, parallel-group, pilot study was conducted from August 2023 to January 2024 at two tertiary university hospitals. A total of 132 patients aged ≥ 65 years with an American Society of Anesthesiologists physical status of 2 or 3 scheduled for elective hip fracture surgery were screened and randomized to receive either an anti-inflammatory drug bundle or a placebo. The primary outcome was postoperative delirium, identified within the first three postoperative days. Postoperative blood inflammatory markers and acute pain were measured for mediation analysis. Results: Of the 132 patients randomized, 123 (93%) completed the trial (mean age, 82 years; 75% women). The prevalence of postoperative delirium was significantly lower in the anti-inflammatory bundle group (15%, 9/62) compared to the placebo group (44%, 27/61) (risk difference, − 30 percentage points [95% CI, − 45 to − 15]; relative risk [RR], 0.33 [95% CI, 0.17 to 0.64]; P = 0.001). No major adverse events were reported in either group. The postoperative CRP level in the anti-inflammatory bundle group was significantly lower (predicted mean difference: − 29.4 [95% CI: − 46.5, − 12.2] mg·L−1; adjusted P < 0.001). Mediation analysis showed a significant indirect association between the anti-inflammatory bundle and postoperative delirium through reduced systemic inflammation (odds ratio [OR], 0.61 [95% CI, 0.26 to 0.87]). Conclusions: This study demonstrates that a perioperative anti-inflammatory bundle significantly reduces the prevalence of postoperative delirium in older patients undergoing hip fracture surgery, without major side effects. Systemic inflammation mediates the protective effect of the intervention. These findings provide preliminary evidence supporting the anti-inflammatory bundle strategy, paving the way for large-scale multicenter trials to optimize postoperative delirium prevention strategies. Trial registration: This study was registered in the Chinese Clinical Trial Registry (ChiCTR2300074303) by Ayixia Nawan on August 3, 2023, prior to patient enrollment.


23 September 2022 in Medicine
Verified
Journal Article
Open access
BJBailin Jiang
Bailin Jiang
YWYaqing Bsc Wu
Yaqing Bsc Wu
XWXiuli Bsc Wang
Xiuli Bsc Wang
YGYu Gan
Yu Gan
PWPeiyao Wei
Peiyao Wei
YFYi Feng
Yi Feng
The evidence regarding the influence of allowing patients to participate in postoperative pain treatment decisions on acute pain management is contradictory. This study aimed to identify the role of patient participation in influencing pain-related patient-reported outcomes (PROs). This is a cross-sectional study. The data were provided by PAIN OUT (www.pain-out.eu). A dataset specific to adult Chinese patients undergoing orthopedic surgery was selected. The PROs were assessed on postoperative day 1. The patient participant was assessed using an 11-point scale. Participants who reported >5 were allocated to the “participation” group, and those who reported ≤5 were allocated to the “nonparticipation” group. A 1:1 propensity score matching was conducted. The primary outcome was the desire for more pain treatment. All other items of PROs were the secondary outcomes comprising pain intensity, interference of pain with function, emotional impairment, adverse effects, and other patient perception. From February 2014 to November 2020, 2244 patients from 20 centers were approached, of whom 1804 patients were eligible and 726 pairs were matched. There was no significant difference between the groups in the desire for more pain treatment either before (25.4% vs 28.2%, risk ratio [95% CI]: 0.90 [0.77, 1.05], P = .18) or after matching (26.7% vs 28.8%, risk ratio [95% CI]: 0.93 [0.79, 1.10], P = .43). After matching, patients in the participation group reported significantly better PROs, including pain intensity (less time spent in severe pain [P < .01]), emotional impairment (less anxiety [P < .01]), interference with function (less interference with sleep [P < .01]), adverse effects (less drowsiness [P = .01]), and patient perception (more pain relief [P < .01] and more satisfaction [P < .01]), than the nonparticipation group. Patient participation in pain treatment decisions was associated with improved pain experience but failed to mitigate the desire for more treatment.

17 September 2022 in European journal of pain
Verified
Journal Article
Closed access
BJBailin Jiang
Bailin Jiang
YLYanhong Liu
Yanhong Liu
YWYaqing Wu
Yaqing Wu
WMWeidong Mi
Weidong Mi
YFYi Feng
Yi Feng

2 September 2025 in Journal of Affective Disorders
Verified
Journal Article
Open access
BJBailin Jiang
Bailin Jiang
YZYiqiyuan Zhang
Yiqiyuan Zhang
ZXZhijuan Xie
Zhijuan Xie
ZWZilong Wu
Zilong Wu
YMYe Ma
Ye Ma
YFYi Feng
Yi Feng
Depressive disorder is a common condition; its standard diagnostic process remains time-consuming due to reliance on mental examinations. This study aimed to validate a novel, non-contact screening tool based on Vibraimage technology and machine learning for rapidly detecting depressive disorder in psychiatric outpatients. In this study, psychiatric outpatients were recruited, underwent a 30-second video capture, which was analyzed using the Mental Health Assessment System. This system quantifies head-neck micro-movements and provides a preliminary depression diagnosis via a machine learning algorithm. The psychiatrists, blinded to the system-generated diagnosis, established the clinical diagnosis of depressive disorder. Diagnostic accuracy was evaluated by calculating the area under the receiver operating characteristic curve (AUC), sensitivity, specificity, and predictive values. Of 1062 patients screened, 601 were enrolled and completed both the video capture and clinical evaluation. Among these, 483 (80.4 %) were clinically diagnosed with depressive disorder. The system achieved a sensitivity of 99.8 % and a specificity of 78.8 %, with positive and negative predictive values of 95.1 % and 98.9 %, respectively, and an overall accuracy of 95.7 %. The AUC was 89.3 % (95 % CI: 85.6-93.0 %). Calibration was excellent (Spiegelhalter Z test, P = 1.000; Brier score = 0.04), and decision curve analysis indicated a net clinical benefit. The Vibraimage-based Mental Health Assessment System demonstrates high diagnostic accuracy for detecting depressive disorder in psychiatric outpatients, offering a rapid, non-invasive screening alternative. Further multicenter studies are warranted to confirm these findings and explore its clinical utility and evaluate the generalizability of these findings to other population. This study was registered at ClinicalTrials.gov (NCT06793176) on January 20, 2025, prior to participant recruitment.

13 February 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
BWBingyi Wang
Bingyi Wang
ZCZitian Chen
Zitian Chen
QHQiaoyu Han
Qiaoyu Han
YFYi Feng
Yi Feng
LJLuyang Jiang
Luyang Jiang
BJBailin Jiang
Bailin Jiang
Background: Hypotension is a common complication following spinal anesthesia, and it is particularly prevalent in older patients. The study aimed to develop and validate a nomogram integrating echocardiographic and clinical predictors for spinal anesthesia-induced hypotension (SAIH) in older patients. Methods: This was an observational cohort study conducted at Peking University People’s Hospital. A total of 865 older patients (age ≥ 65), enrolled from 1 January 2023 to 31 December 2024, were randomly split into a training set (70%) and an internal validation set (30%). For temporal external validation, 349 patients from January to March 2025 were enrolled. LASSO, univariable, and multivariate logistic regression analyses were used to identify predictive factors. A nomogram was subsequently developed based on the results of multivariate logistic regression, and its predictive efficacy was evaluated via both internal and temporal external validation. Results: SAIH occurred in 271 patients (44.8%) in the training set, 110 patients (42.3%) in the internal validation set, and 173 patients (49.6%) in the external validation set. Age, body mass index (BMI), bupivacaine dose, sensory block level, baseline systolic blood pressure (SBP), history of hypertension, interventricular septum thickness at end-diastole (IVSd), early diastolic mitral annular velocity (e’), and E/e’ ratio were significant predictors of SAIH on multivariate analysis. The diagnostic performance of the nomogram was favorable (AUC = 0.885, 95% CI: 0.859–0.911). The AUC values of the internal validation set and temporal external validation set were 0.856 (0.811–0.901) and 0.895 (0.863–0.927). Conclusions: This study identifies age, BMI, bupivacaine dose, sensory block level, baseline SBP, history of hypertension, and IVSd as predictors of SAIH with good discrimination and clinical utility. We present a predictive nomogram that accurately predicts SAIH in older patients. The external validation illustrates its generalizability.